EcoDrugPlus

Adrenoceptor Alpha 1b

Ensembl ID : ENSBSLG00000010220
Gene Symbol: ADRA1B
2 Cross references
192 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSBSLG00000015024
Gene Symbol: ADRA1D
2 Cross references
195 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSBSLG00000008461
Gene Symbol: ADRA2A
3 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSBSLG00000011940
Gene Symbol: ADRA2C
3 Cross references
156 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSBSLG00000021769
Gene Symbol: ADRB1
3 Cross references
163 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B1-Like

Ensembl ID : ENSBSLG00000011091
Gene Symbol: LOC114862619
3 Cross references
350 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B10-Like

Ensembl ID : ENSBSLG00000010511
Gene Symbol: LOC114862618
3 Cross references
348 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSBSLG00000019342
Gene Symbol: GAA
3 Cross references
233 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSBSLG00000025240
Gene Symbol: LOC114863187
3 Cross references
202 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSBSLG00000007914
Gene Symbol: LOC114861549
3 Cross references
175 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSBSLG00000012843
Gene Symbol: LOC114866952
2 Cross references
156 Possible Orthologues:

Alpha-2c Adrenergic Receptor-Like

Ensembl ID : ENSBSLG00000002197
Gene Symbol: LOC114856932
3 Cross references
162 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).